Summary
Global Markets Directs, Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2012, provides an overview of the Genital Warts (Condylomata Acuminata) therapeutic pipeline. This report provides information on the therapeutic development for Genital Warts (Condylomata Acuminata), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Genital Warts (Condylomata Acuminata). Genital Warts (Condylomata Acuminata) - Pipeline Review, H1 2012 is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Genital Warts (Condylomata Acuminata).
- A review of the Genital Warts (Condylomata Acuminata) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
Table of contents:
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report
Coverage 5
Genital Warts (Condylomata Acuminata) Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Genital Warts (Condylomata Acuminata) 7
Genital Warts (Condylomata Acuminata) Therapeutics under Development by Companies 9
Late Stage Products 10
Comparative Analysis 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Discovery and Pre-Clinical Stage Products 12
Comparative Analysis 12
Genital Warts (Condylomata Acuminata) Therapeutics Products under Development by Companies 13
Companies Involved in Genital Warts (Condylomata Acuminata) Therapeutics Development 14
Helix BioPharma Corp. 14
Inovio Biomedical Corporation 15
Merck Co., Inc. 16
MediGene AG 17
Anaconda Pharma 18
Telormedix SA 19
Genetic Immunity, LLC 20
Moberg Derma AB 21
Genital Warts (Condylomata Acuminata) Therapeutics Assessment 22
Assessment by Monotherapy Products 22
Assessment by Route of Administration 23
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1 2012PubId=pagenum=1
Tachycardia (Tachyarrhythmias) Pipeline Review, H1 2012
Genital Warts (Condylomata Acuminata) Pipeline Review, H1 2012
Gingivitis Pipeline Review, H1 2012
West Nile Virus Infections Pipeline Review, H1 2012
Pompe Disease Pipeline Review, H1 2012
Bronchiolitis Obliterans Pipeline Review, H1 2012
Cancer Cachexia Pipeline Review, H1 2012
Hyperuricemia Pipeline Review, H1 2012
Sarcoidosis Pipeline Review, H1 2012
Optic Nerve Injury Pipeline Review, H1 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and HealthcarePubId=pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com
